ScholarIQanswers from OpenAlex & ORCID
Sang Hoon Ahn
ResearcherPublications, citations & collaboration network
Sang Hoon Ahn is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Sang Hoon Ahn have?
ScholarIQindexed works
Sang Hoon Ahn has 1,166 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Sang Hoon Ahn have?
ScholarIQcitation count
Sang Hoon Ahn has 28,660 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Sang Hoon Ahn?
ScholarIQh-index
Sang Hoon Ahn has an h-index of 75 in OpenAlex.
What is the i10-index of Sang Hoon Ahn?
ScholarIQi10-index
Sang Hoon Ahn has an i10-index of 452 in OpenAlex.
What is the ORCID of Sang Hoon Ahn?
ScholarIQorcid
The ORCID for Sang Hoon Ahn is on the source record.
What is the OpenAlex record for Sang Hoon Ahn?
ScholarIQopenalex
The OpenAlex for Sang Hoon Ahn is on the source record.
What are the most-cited papers on Sang Hoon Ahn?
ScholarIQmost cited works
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam, Philip N. Newsome, Shiv Kumar Sarin, Quentin M. Anstee, Giovanni Targher, Manuel Romero‐Gómez, Shira Zelber‐Sagi, Vincent Wai‐Sun Wong, Jean‐François Dufour, Jörn M. Schattenberg, Takumi Kawaguchi, Marco Arrese, Luca Valenti, Gamal Shiha, Claudio Tiribelli, Hannele Yki‐Järvinen, Jian-Gao Fan, Henning Grønbæk, Yusuf Yılmaz, Helena Cortez‐Pinto, Cláudia P. Oliveira, Pierre Bédossa, Leon A. Adams, Ming‐Hua Zheng, Yasser Fouad, Wah‐Kheong Chan, Nahúm Méndez‐Sánchez, Sang Hoon Ahn, Laurent Castéra, Elisabetta Bugianesi, Vlad Ratziu, Jacob George
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Mohammed Eslam, Shiv Kumar Sarin, Vincent Wai‐Sun Wong, Jian-Gao Fan, Takumi Kawaguchi, Sang Hoon Ahn, Ming‐Hua Zheng, Gamal Shiha, Yusuf Yılmaz, Rino Alvani Gani, Shahinul Alam, Yock Young Dan, Jia‐Horng Kao, Saeed Hamid, Ian Homer, Wah‐Kheong Chan, Diana A. Payawal, Soek-Siam Tan, Tawesak Tanwandee, Leon A. Adams, Manoj Kumar, Masao Omata, Jacob George
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Hwai‐I Yang, Man‐Fung Yuen, Henry Lik‐Yuen Chan, Kwang‐Hyub Han, Pei‐Jer Chen, Do Young Kim, Sang Hoon Ahn, Chien‐Jen Chen, Vincent Wai‐Sun Wong, Wai‐Kay Seto
Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients
Beom Kyung Kim, Do Young Kim, Jun Yong Park, Sang Hoon Ahn, Chae Yoon Chon, Ja Kyung Kim, Yong Han Paik, Kwan Sik Lee, Young Nyun Park, Kwang‐Hyub Han
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
Shiv Kumar Sarin, Ashok Choudhury, George Lau, Ming‐Hua Zheng, Dong Ji, Sherief Abd‐Elsalam, Jae-Seok Hwang, Xiaolong Qi, Ian Homer, Jeong Ill Suh, Jun Gi Park, Opass Putcharoen, Apichat Kaewdech, Teerha Piratvisuth, Sombat Treeprasertsuk, Soo Young Park, Salisa Wejnaruemarn, Diana A. Payawal, Oidov Baatarkhuu, Sang Hoon Ahn, Chang Dong Yeo, Uzziel Romar Alonzo, Tserendorj Chinbayar, Imelda Maria Loho, Osamu Yokosuka, Wasim Jafri, Soek-Siam Tan, Lau Ing Soo, Tawesak Tanwandee, Rino Alvani Gani, Lovkesh Anand, Eslam Saber Esmail, Mai Khalaf, Shahinul Alam, Chun‐Yu Lin, Wan‐Long Chuang, Arvinder S. Soin, Hitendra Garg, Kemal Fariz Kalista, Badamnachin Batsukh, Hery Djagat Purnomo, Vijay Pal Dara, Pravin Rathi, Mamun Al Mahtab, Akash Shukla, Manoj K. Sharma, Masao Omata, APASL COVID Task Force, APASL COVID Liver Injury Spectrum Study (APCOLIS Study-NCT 04345640)